Antibiotics given to entire household reduces risk of meningitis

Giving antibiotics to everyone living in the same household as a patient who has had meningitis can substantially reduce the risk of further cases, according to a study in this week's BMJ.

Researchers analysed five studies to evaluate the effectiveness of giving chemoprophylaxis (preventive medicine) to the patient and to contacts in households and childcare settings.

They found that the risk of meningococcal disease in household contacts of a patient is reduced by 89% if they take antibiotics that eradicate meningococcal carriage. Another way of expressing this risk reduction across a population is that about 200 household contacts need to be treated to prevent one case during the first month.

The evidence also suggests giving preventive treatment to the patient before discharge from hospital, as at least 3% of patients will still carry the virulent meningococcal strain after treatment with penicillin.

However, there was no evidence to support indiscriminate prescribing of antibiotic prophylaxis to people outside this group, and there were insufficient studies to estimate the effect of chemoprophylaxis in childcare settings.

So far, a lack of evidence has led to different control policies across Europe. This paper reinforces current UK policy and provides sufficient evidence to encourage further consistency, conclude the authors.

Click here to view full paper: http://press.psprings.co.uk/bmj/june/ppr1339.pdf

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
West Nile virus surges to highest incidence since 2012